Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
N Engl J Med 375:18341844 Thompson AM, Trujillo JM (2015) Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes
Ozempic (aka semaglutide), is FDA approved for Type II diabetes and has multiple studies that show benefits for weight loss and improvement, particularly in patients with knee arthritis
Each vial of Tirzepatide undergoes rigorous quality testing to maintain unmatched purity and performance standards
Warnings Contains no: Gluten, soy, wheat, corn, eggs, dairy, yeast, citrus, preservatives, artificial flavour or colour, starch, or sugar
Why Protein Matters for GLP-1 Users GLP-1 medications work by slowing digestion, increasing insulin sensitivity, and reducing hunger cues, leading to a natural decrease in food intake
